Current position:Home >Product >
Piperazine, 1-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-4- methyl-, rel-
Piperazine, 1-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-4- methyl-, rel-(404908-80-1)
- Name: Piperazine, 1-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-4- methyl-, rel-
- Synonyms:
- Molecular Formula:C17H25N5O2
- Molecular Weight:
- CAS Registry Number:404908-80-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 404908-63-0/1H-Naphtho[2,3-c]pyran-1-ol, 3,4-dihydro-5,10-dimethoxy-3-methyl-, (1R,3S)-rel-
- 404908-65-2/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[4-(aminoiminomethyl)phenyl]-, (2R,4S)-rel-
- 404908-66-3/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(4-methoxyphenyl)methyl]-1-(phen ylmethyl)-, (2R,4S)-rel-
- 404908-67-4/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[4-(aminoiminomethyl)phenyl]-1-[(2 -nitrophenyl)methyl]-, (2R,4S)-rel-
- 404908-68-5/1H-Naphtho[2,3-c]pyran-5,10-dione, 3,4-dihydro-1-hydroxy-3-methyl-, (1R,3S)-rel-
- 404908-70-9/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(4-methoxyphenyl)methyl]-, (2R,4S)-rel-
- 404908-71-0/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(4-methylphenyl)methyl]-, (2R,4S)-rel-
- 404908-72-1/Isoquinoline, 2-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-1, 2,3,4-tetrahydro-, rel-
- 404908-73-2/Isoquinoline, 2-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-1, 2,3,4-tetrahydro-6,7-dimethoxy-, rel-
- 404908-74-3/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[2-(2,3-dihydro-1H-indol-3-yl)ethyl]- , (2R,4S)-rel-
- 404908-75-4/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(3-methylphenyl)methyl]-, (2R,4S)-rel-
- 404908-77-6/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-methyl-N,1-bis(phenylmethyl)-, (2R,4S)-rel-
- 404908-79-8/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-1-benzoyl-N-(4-chlorophenyl)-, (2R,4S)-rel-
- 404908-80-1/Piperazine, 1-[[(2R,4S)-4-[3-(aminoiminomethyl)phenoxy]-2-pyrrolidinyl]carbonyl]-4- methyl-, rel-
- 404908-81-2/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(3-chlorophenyl)methyl]-, (2R,4S)-rel-
- 404908-83-4/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-(2-naphthalenylmethyl)-, (2R,4S)-rel-
- 404908-86-7/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[4-(aminoiminomethyl)phenyl]-1-[(4 -nitrophenyl)methyl]-, (2R,4S)-rel-
- 404908-87-8/2-Pyrrolidinecarboxamide, 1-acetyl-4-[3-(aminoiminomethyl)phenoxy]-N-[(4-methoxyphenyl)methyl] -, (2R,4S)-rel-
- 404908-88-9/1,2-Propanediol, 3-(3-bromo-1,4-dimethoxy-2-naphthalenyl)-, (2R)-
- 404908-89-0/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[4-(trifluoromethyl)phenyl]-, (2R,4S)-rel-
- 404908-90-3/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-(2,3-dihydro-1H-inden-1-yl)-, (2R,4S)-rel-
- 404908-91-4/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(1R)-1-phenylethyl]-, (2S,4R)-rel-
- 404908-92-5/L-Proline, 4-[3-(aminoiminomethyl)phenoxy]-, 2-propenyl ester, (4R)-
- 404908-93-6/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[1,1'-biphenyl]-4-yl-, (2R,4S)-rel-
- 404908-94-7/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-2-naphthalenyl-, (2R,4S)-rel-
- 404908-95-8/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-[(4-aminophenyl)methyl]-, (2R,4S)-rel-
- 404908-96-9/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-2-propenyl-, (2R,4S)-rel-
- 404908-98-1/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-1-naphthalenyl-, (2R,4S)-rel-
- 404908-99-2/2-Pyrrolidinecarboxamide, 4-[3-(aminoiminomethyl)phenoxy]-N-(4-cyanophenyl)-, (2R,4S)-rel-
- 404909-01-9/L-Proline, 4-[3-(aminoiminomethyl)phenoxy]-1-benzoyl-, 2-propenyl ester, (4R)-